These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
87 related items for PubMed ID: 23867597
1. Correlation between imaging and molecular classification of breast cancers. Boisserie-Lacroix M, Hurtevent-Labrot G, Ferron S, Lippa N, Bonnefoi H, Mac Grogan G. Diagn Interv Imaging; 2013 Nov; 94(11):1069-80. PubMed ID: 23867597 [Abstract] [Full Text] [Related]
2. Correlation between imaging and prognostic factors: molecular classification of breast cancers. Boisserie-Lacroix M, Bullier B, Hurtevent-Labrot G, Ferron S, Lippa N, Mac Grogan G. Diagn Interv Imaging; 2014 Feb; 95(2):227-33. PubMed ID: 24508482 [Abstract] [Full Text] [Related]
3. Correlation between MR imaging - prognosis factors and molecular classification of breast cancers. Alili C, Pages E, Curros Doyon F, Perrochia H, Millet I, Taourel P. Diagn Interv Imaging; 2014 Feb; 95(2):235-42. PubMed ID: 24525088 [Abstract] [Full Text] [Related]
4. Molecular classification of infiltrating breast cancer: toward personalized therapy. Trop I, LeBlanc SM, David J, Lalonde L, Tran-Thanh D, Labelle M, El Khoury MM. Radiographics; 2014 Feb; 34(5):1178-95. PubMed ID: 25208275 [Abstract] [Full Text] [Related]
5. Can breast cancer molecular subtype help to select patients for preoperative MR imaging? Grimm LJ, Johnson KS, Marcom PK, Baker JA, Soo MS. Radiology; 2015 Feb; 274(2):352-8. PubMed ID: 25325325 [Abstract] [Full Text] [Related]
6. Prognostic significance of molecular classification of breast invasive ductal carcinoma. Muñoz M, Fernández-Aceñero MJ, Martín S, Schneider J. Arch Gynecol Obstet; 2009 Jul; 280(1):43-8. PubMed ID: 19082617 [Abstract] [Full Text] [Related]
9. Breast cancer molecular subtype as a predictor of the utility of preoperative MRI. Ha R, Jin B, Mango V, Friedlander L, Miloshev V, Malak S, Wynn R. AJR Am J Roentgenol; 2015 Jun; 204(6):1354-60. PubMed ID: 26001248 [Abstract] [Full Text] [Related]
11. Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy. Goldstein NS, Decker D, Severson D, Schell S, Vicini F, Margolis J, Dekhne NS. Cancer; 2007 Oct 15; 110(8):1687-96. PubMed ID: 17722109 [Abstract] [Full Text] [Related]
13. "New" molecular taxonomy in breast cancer. Hergueta-Redondo M, Palacios J, Cano A, Moreno-Bueno G. Clin Transl Oncol; 2008 Dec 15; 10(12):777-85. PubMed ID: 19068448 [Abstract] [Full Text] [Related]
14. Invasive lobular carcinoma: detection with mammography, sonography, MRI, and breast-specific gamma imaging. Brem RF, Ioffe M, Rapelyea JA, Yost KG, Weigert JM, Bertrand ML, Stern LH. AJR Am J Roentgenol; 2009 Feb 15; 192(2):379-83. PubMed ID: 19155397 [Abstract] [Full Text] [Related]
15. Molecular subtypes of breast carcinoma in Egyptian women: clinicopathological features. El-Hawary AK, Abbas AS, Elsayed AA, Zalata KR. Pathol Res Pract; 2012 Jul 15; 208(7):382-6. PubMed ID: 22641056 [Abstract] [Full Text] [Related]
16. Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas. Fernandes RC, Bevilacqua JL, Soares IC, Siqueira SA, Pires L, Hegg R, Carvalho FM. Histopathology; 2009 Sep 15; 55(3):346-52. PubMed ID: 19723150 [Abstract] [Full Text] [Related]